A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)

Clinical trial NCT00577668 · WITHDRAWN

Trial details

NCT number: NCT00577668
Sponsor: University of Arkansas
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2007-04-01
Primary completion: 2009-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.